Seeing Is Believing

Currently out of the existing stock ratings of Eliana Merle, 191 are a BUY (82.68%), 40 are a HOLD (17.32%).
Analyst Eliana Merle, currently employed at BARCLAYS, carries an average stock price target met ratio of 46.99% that have a potential upside of 45.44% achieved within 238 days. Previously, Eliana Merle worked at UBS, CANTOR FITZGERALD.
Eliana Merle’s has documented 441 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 1/28/2025. The price target of $2.2 was fulfilled within 1 day with a profit of $0.2 (8.33%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
3 months 27 days ago
(15-May-2026)
4/22 (18.18%)
$13.11 (73.28%)
308
Buy Since 20-Jan-2026
$41
$37.88 (1214.10%)
$26
4 months 25 days ago
(17-Apr-2026)
15/18 (83.33%)
$0.1 (0.24%)
100
Hold Since 02-Nov-2023
$41
$37.88 (1214.10%)
$20
5 months 9 days ago
(02-Apr-2026)
14/19 (73.68%)
$0.59 (1.46%)
147
Buy Since 04-Dec-2017
$41
$37.88 (1214.10%)
$44
5 months 10 days ago
(01-Apr-2026)
22/29 (75.86%)
$0.61 (1.51%)
214
Buy Since 19-Jan-2024
$41
$37.88 (1214.10%)
$45
5 months 10 days ago
(01-Apr-2026)
16/28 (57.14%)
$0.61 (1.51%)
368
Which stock is Eliana Merle most bullish on?
Which stock is Eliana Merle most reserved on?
What Year was the first public recommendation made by Eliana Merle?